0 CHECKOUT

PRODUCT FILTERS

REGION

105
37
24
22
22

COUNTRY

19
7
7
6
6

CATEGORIES

  • 103
  • 50
  • 39
  • 23
  • 22
  • 13
  • 13
  • 13
  • 13
  • 12
  • 12
  • 10
  • 10
  • 8
  • 7
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

44
121
164
351

PUBLISHED

5
24
77
351

PRODUCT TYPE

211
96
32
8
2
1
1

Search for: "Disease and Therapy Review: Lung Cancer"

Metastatic Lung Cancer-Pipeline Insights

Summary Metastatic Lung Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Metastatic Lung Cancer. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015 Summary the, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic...

Published:  June 2015
Price:  From

Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

Non-Small Cell Lung Cancer - Pipeline Review, H2 2015 Summary The report ‘Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic...

Published:  December 2015
Price:  From

Squamous Non-Small Cell Lung Cancer-Pipeline Insights

Summary Squamous Non-Small Cell Lung Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Squamous Non-Small Cell Lung Cancer. The main objective of this report...

Published:  February 2016
Price:  From

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Non-Small...

Published:  March 2014
Price:  From

NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

""NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool"", which provides in-depth insights into the...

Published:  March 2014
Price:  From

Personalizing Cancer Drugs Trends

The report illustrates that understanding of cancer is shifting from a pathology-oriented perspective to a molecular perception Mechanisms responsible for driving cancer continue to emerge in diverse...

Published:  January 2014
Price:  From

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

Published:  January 2016
Price:  From

The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact

In 2010, the therapeutic cancer vaccine market witnessed several key milestones Dendreon's Provenge (sipuleucel-T) became the first product to reach the market; gaining long-awaited FDA approval for...

Published:  January 2011
Price:  From

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

Published:  March 2013
Price:  From

Radiation Therapy Equipment - Global Strategic Business Report

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator....

Published:  January 2015
Price:  From

Lung Cancer. 4th Edition

The best and most concise single source for state-of-the-art diagnosis and treatment of lung cancer –newly revised, updated, and expanded. Lung cancer has long been the number-one cause of death...

Published:  May 2014
Price: 

Small-Cell Lung Cancer - Pipeline Review, H2 2015

Small-Cell Lung Cancer - Pipeline Review, H2 2015 Summary The report ‘Small-Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Small-Cell Lung Cancer - Pipeline Review, H1 2015

Small-Cell Lung Cancer - Pipeline Review, H1 2015 Summary This, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

Metastatic Lung Cancer - Pipeline Review, H1 2013

'Metastatic Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Metastatic Lung...

Published:  April 2013
Price:  From

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015 Summary The report ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Squamous Non-Small Cell...

Published:  August 2015
Price:  From

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015 Summary This, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung...

Published:  January 2015
Price:  From

Lung Cancer Global Clinical Trials Review, H2, 2011

Lung Cancer Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Lung Cancer Global Clinical Trials Review, H2, 2011" provides data on the Lung Cancer clinical trial...

Published:  November 2011
Price:  From

Metastatic Lung Cancer - Pipeline Review, H2 2013

Metastatic Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

Published:  October 2013
Price:  From

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant' provides in-depth analysis...

Published:  April 2014
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group